EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Evaluation of the CARBA PAcE test, a colorimetric imipenem hydrolysis test for rapid detection of carbapenemase activity

Nadya Rakovitsky iD, Mor N Lurie-Weinberger, Elizabeth Temkin, Amichay Hameir, Reut Efrati-Epchtien, Liat Wulffhart, Alona Keren Paz, David Schwartz, Yehuda Carmeli iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.00891-24 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Nadya Rakovitsky und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Antibiotic Resistance and Infection Control, Israel Ministry of Health, Tel Aviv, Israel. Hauptthemen laut MEDLINE: beta-Lactamases, Imipenem, Bacterial Proteins, Colorimetry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is an urgent need for accurate and fast diagnostic tests to identify carbapenemase-producing bacteria. Here, we evaluated a colorimetric imipenem hydrolysis test, called the CARBA PAcE test, to detect carbapenemase-producing Gram-negative bacteria (GNB). We tested a collection of 270 GNB isolates with a characterized carbapenemase content. Our testing set included 205 carbapenemase-producing, carbapenemase-resistant Enterobacterales ( CP CRE ) with 40 Klebsiella pneumoniae carbapenemase (KPC), 49 New Delhi metallo beta lactamase (NDM), 49 OXA-48-like, 15 Verona integron-mediated metallo-β-lactamase (VIM), three IMP, 43 IMI, six isolates producing more than one carbapenemase, and 65 non-carbapenemase-producing Enterobacterales (20 ESBL producers, 35 non-carbapenemase-producing, carbapenem-resistant [non-CP CRE], and 10 carbapenem-susceptible Enterobacterales [non-CP, non-CSE, third-generation cephalosporin and carbapenem susceptible]). We compared the performances of the CARBA PAcE test, the qualitative colorimetric β-CARBA test, and the modified CarbaNP test to a gold standard of carbapenemase gene detection by PCR. Specificities of all tests were high: 95.4% (62/65) for CARBA PAcE test, 98.5% (64/65) for β-CARBA test, and 100% (65/65) for the modified CarbaNP test. Sensitivity varied by carbapenemase: all three tests had a sensitivity of 100% for NDM, VIM, and IMP and 97.5% for KPC. Sensitivity to detect IMI was 0% for the CARBA PAcE and β-CARBA tests and 11.6% for the modified CarbaNP test. Sensitivity to detect OXA-48-like was 89.7% for the CARBA PAcE test, 87.7% for the β-CARBA test, and 14.2% for the modified CarbaNP test. Reading the results of the CARBA PAcE assay was difficult. The CARBA PAcE assay is highly sensitive for detecting NDM, VIM, IMP, and KPC, but slightly less sensitive for OXA-48-like. It does not detect IMI. It is highly specific, and its overall diagnostic accuracy is similar to that of β-CARBA. Its operational advantages are rapid turnaround time, ease of use, and long shelf life, but reading of results is subjective. IMPORTANCE We evaluated the ability of the CARBA PAcE test to detect carbapenemases in 274 Gram-negative isolates with a known carbapenemase content. Specificity was high for all carbapenemases tested (96.9%). Sensitivity was high for KPC, NDM, VIM, and IMP (97.5-100%); but lower for OXA-48-like (89.7%). Activity of IMI could not be detected. Taken together, our results indicate that CARBA PAcE is a useful alternative in regions where NDM and KPC are predominant. The limitations of the test are difficulty in reading results and incompatibility with mSuperCARBA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesImipenemBacterial ProteinsColorimetryGram-Negative BacteriaHumansHydrolysisAnti-Bacterial AgentsSensitivity and SpecificityMicrobial Sensitivity Tests

Stichwörter der Autor:innen

CARBA PAcEcarbapenem resistancecarbapenemasecolorimetric testimipenem hydrolysis testβ CARBA

Substanzen

beta-LactamasescarbapenemaseImipenemBacterial ProteinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • National Institute for Antibiotic Resistance and Infection Control, Israel Ministry of Health, Tel Aviv, Israel.
  • School of Medicine, Tel Aviv University, Tel Aviv, Israel.

ORCID-Profile: Nadya Rakovitsky, Yehuda Carmeli

Zitieren

APA

Rakovitsky, N., Lurie-Weinberger, M. N., Temkin, E., Hameir, A., Efrati-Epchtien, R., Wulffhart, L., Keren Paz, A., Schwartz, D., & Carmeli, Y. (2024). Evaluation of the CARBA PAcE test, a colorimetric imipenem hydrolysis test for rapid detection of carbapenemase activity. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00891-24

Vancouver

Rakovitsky N, Lurie-Weinberger MN, Temkin E, Hameir A, Efrati-Epchtien R, Wulffhart L, et al. Evaluation of the CARBA PAcE test, a colorimetric imipenem hydrolysis test for rapid detection of carbapenemase activity. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00891-24

BibTeX
@article{Rakovitsky2024,
  author = {Rakovitsky, Nadya and Lurie-Weinberger, Mor N and Temkin, Elizabeth and Hameir, Amichay and Efrati-Epchtien, Reut and Wulffhart, Liat and Keren Paz, Alona and Schwartz, David and Carmeli, Yehuda},
  title = {Evaluation of the CARBA PAcE test, a colorimetric imipenem hydrolysis test for rapid detection of carbapenemase activity},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.00891-24}
}
Kostenlos starten →